[go: up one dir, main page]

SK2694U - Aminokyselinové nukleové kyseliny - Google Patents

Aminokyselinové nukleové kyseliny

Info

Publication number
SK2694U
SK2694U SK165-97U SK16597U SK2694U SK 2694 U SK2694 U SK 2694U SK 16597 U SK16597 U SK 16597U SK 2694 U SK2694 U SK 2694U
Authority
SK
Slovakia
Prior art keywords
amino acid
nucleic acids
acid nucleic
acids
amino
Prior art date
Application number
SK165-97U
Other languages
English (en)
Slovak (sk)
Inventor
Kandasamy Ramasamy
Guangyi Wang
Wilfried Seifert
Original Assignee
Icn Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceutical Inc filed Critical Icn Pharmaceutical Inc
Publication of SK2694U publication Critical patent/SK2694U/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK165-97U 1994-11-02 1995-11-02 Aminokyselinové nukleové kyseliny SK2694U (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33389594A 1994-11-02 1994-11-02

Publications (1)

Publication Number Publication Date
SK2694U true SK2694U (sk) 2000-11-07

Family

ID=23304698

Family Applications (1)

Application Number Title Priority Date Filing Date
SK165-97U SK2694U (sk) 1994-11-02 1995-11-02 Aminokyselinové nukleové kyseliny

Country Status (14)

Country Link
EP (1) EP0789707A4 (fr)
JP (1) JPH10508312A (fr)
KR (1) KR100393336B1 (fr)
CN (1) CN1171112A (fr)
AU (1) AU693622B2 (fr)
CA (1) CA2202274A1 (fr)
HU (1) HU218086B (fr)
MX (1) MX9703188A (fr)
PL (1) PL185852B1 (fr)
RU (1) RU2154638C2 (fr)
SI (1) SI9520112A (fr)
SK (1) SK2694U (fr)
UA (1) UA48150C2 (fr)
WO (1) WO1996014330A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840879A (en) * 1996-12-06 1998-11-24 Wang; Edge R. Reagents and solid supports for improved synthesis and labeling of polynucleotides
CZ301401B6 (cs) * 1999-12-22 2010-02-17 Metabasis Therapeutics, Inc. Bisamidátfosfonátová predléciva a farmaceutické prostredky s jejich obsahem
EP2302387A1 (fr) * 2001-04-10 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Utilisations thérapeutiques et diagnostiques de profils de spécificité des anticorps pour les diabètes non dépendants de l'insuline
WO2009064471A1 (fr) * 2007-11-15 2009-05-22 Avi Biopharma, Inc. Procédé de synthèse d'oligomères morpholino
US8865898B2 (en) 2010-11-30 2014-10-21 Japan Science And Technology Agency Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
RU2460721C1 (ru) * 2011-02-25 2012-09-10 Учреждение Российской академии наук Институт химической биологии и фундаментальной медицины Сибирского отделения РАН (ИХБФМ СО РАН) Способ получения амидофосфитного мономера ахиральной ненуклеотидной вставки для модификации олигонуклеотидов
DE102014007158A1 (de) * 2014-05-16 2015-11-19 Ugichem Gmbh Neue Peptid-Nukleinsäuren-Monomere und -Oligomere
WO2018230624A1 (fr) * 2017-06-16 2018-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 Composé monomère d'acide nucléique modifié et analogue d'acide oligonucléique
CN113956183B (zh) * 2021-10-28 2023-06-20 成都市科隆化学品有限公司 一种Boc-Ser(Bzl)-OH及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687030T2 (de) * 1985-03-15 1993-03-11 Eugene Stirchak Stereoregulare polynukleotiden bindende polymere.
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf

Also Published As

Publication number Publication date
AU4234196A (en) 1996-05-31
EP0789707A4 (fr) 1999-02-24
WO1996014330A1 (fr) 1996-05-17
CN1171112A (zh) 1998-01-21
KR970707144A (ko) 1997-12-01
JPH10508312A (ja) 1998-08-18
UA48150C2 (uk) 2002-08-15
EP0789707A1 (fr) 1997-08-20
HU218086B (hu) 2000-05-28
MX9703188A (es) 1997-12-31
RU2154638C2 (ru) 2000-08-20
PL320084A1 (en) 1997-09-15
AU693622B2 (en) 1998-07-02
SI9520112A (sl) 1998-08-31
CA2202274A1 (fr) 1996-05-17
KR100393336B1 (ko) 2003-12-24
HUT77435A (hu) 1998-04-28
PL185852B1 (pl) 2003-08-29

Similar Documents

Publication Publication Date Title
FI953837L (fi) Synteettisiä aktivoituvia aminohappoja
ATE238984T1 (de) Sulfonylaminocarbonsäuren
FI954329A0 (fi) Farmaseuttisina aineina käytettäviä nukleiinihappoja
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
FI961283A7 (fi) Tehokkaan nukleiinihapposekvensoinnin menetelmiä ja koostumuksia
DE69841895D1 (de) Nukleinsäuretestverfahren
NO960408D0 (no) DNA sekvenseringsenzymer
FI970648A7 (fi) Menetelmä nukleiinihappojen jakelemiseksi
DE69718600D1 (de) Polyether-Nukleinsäuren
DE4496581T1 (de) Nucleinsäure-Sequenzierungsgele
NO993901D0 (no) Bisykliske aminosyrer
FI964423L (fi) DNA-sekvenssit
FI950586A7 (fi) Aminohappojohdos
DE69606053D1 (de) Modifizierte fluorsulfonsäure
SK2694U (sk) Aminokyselinové nukleové kyseliny
IS4629A (is) Samskeyttar veirukjarnsýrur
DE59809733D1 (de) Hbv-gerichtete antisense-nukleinsäuren
FI970195L (fi) Trifluormetyylikinoliinikarboksyylihappojohdannainen
GB9420010D0 (en) Nucleic acids
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime
DE69508700D1 (de) Aminosäurederivat mit Anti-CCK-Aktivität
GB9408064D0 (en) Nucleic acids
BR9508824A (pt) Derivado de ácido imícido
NO974296D0 (no) Aminosyreforbindelse
SE9503923D0 (sv) New amino acid derivatives